Lymphastat V
NDC 44911-0732, Echinacea (Angustifolia), Lomatium Dissectum, Hydrastis Canadensis, Sambucus Nigra, Aconitum Napellus, Anas Barbariae, Hepatis Et Cordis Extractum, Arsenicum Album, Belladonna, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lachesis Mutus, Rhus Tox, Pyrogenium, Influenzinum (2023-2024), liquid, from Energique, Inc..
- Product NDC
- 44911-0732
- Status
- Listed
- Labeler
- Energique, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0732 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ECHINACEA ANGUSTIFOLIA WHOLE3 [hp_X]/mL
- LOMATIUM DISSECTUM ROOT3 [hp_X]/mL
- GOLDENSEAL6 [hp_X]/mL
- SAMBUCUS NIGRA FLOWERING TOP6 [hp_X]/mL
- ACONITUM NAPELLUS WHOLE12 [hp_X]/mL
- CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE12 [hp_X]/mL
- ARSENIC TRIOXIDE12 [hp_X]/mL
- ATROPA BELLADONNA12 [hp_X]/mL
- BRYONIA ALBA ROOT12 [hp_X]/mL
- EUPATORIUM PERFOLIATUM FLOWERING TOP12 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT12 [hp_X]/mL
- LACHESIS MUTA VENOM12 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF12 [hp_X]/mL
- RANCID BEEF30 [hp_X]/mL
- INFLUENZA A VIRUS WHOLE12 [hp_C]/mL
- INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE12 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE12 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE12 [hp_C]/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0732-1 | 44911073201 | 30 mL in 1 BOTTLE, DROPPER (44911-0732-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0732 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0732 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0732. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.